← Back to Clinical Trials
Recruiting NCT07488377

NCT07488377 Turkish Cognitive Self-Efficacy Questionnaire in Parkinson's Disease

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07488377
Status Recruiting
Phase
Sponsor Acibadem University
Condition Parkinson Disease
Study Type OBSERVATIONAL
Enrollment 100 participants
Start Date 2026-04-01
Primary Completion 2027-01-01

Eligibility & Interventions

Sex All sexes
Min Age 40 Years
Max Age 85 Years
Study Type OBSERVATIONAL
Interventions
Cognitive Self-Efficacy Questionnaire (Turkish Version)

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 100 participants in total. It began in 2026-04-01 with a primary completion date of 2027-01-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study aims to evaluate the validity and reliability of the Turkish version of the Cognitive Self-Efficacy Questionnaire in individuals with Parkinson's disease.

Eligibility Criteria

Inclusion Criteria: * Clinical diagnosis of Parkinson's disease * Hoehn and Yahr stage 1-3 * Age 40 to 85 years * Mini-Mental State Examination (MMSE) score ≥24 * Able to communicate and complete study assessments * Attending the Movement Disorders Outpatient Clinic, Department of Neurology, Istanbul Cerrahpaşa Faculty of Medicine Hospital * Able and willing to provide written informed consent Exclusion Criteria: * Major depressive disorder or psychotic disorder * Advanced dementia * Severe visual impairment that may interfere with study assessments * Severe hearing impairment that may interfere with study assessments * Inability to cooperate with the physiotherapist * Inability to complete the study assessments

Contact & Investigator

Central Contact

Nuray ALACA

✉ nuray.alaca@acibadem.edu.tr

📞 05324251290

Frequently Asked Questions

Who can join the NCT07488377 clinical trial?

This trial is open to participants of all sexes, aged 40 Years or older, up to 85 Years, studying Parkinson Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07488377 currently recruiting?

Yes, NCT07488377 is actively recruiting participants. Contact the research team at nuray.alaca@acibadem.edu.tr for enrollment information.

Where is the NCT07488377 trial being conducted?

This trial is being conducted at Istanbul, Turkey (Türkiye).

Who is sponsoring the NCT07488377 clinical trial?

NCT07488377 is sponsored by Acibadem University. The trial plans to enroll 100 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology